The Pink Vaccine

The Pink Vaccine

During the summer of 2010, Dr. Vincent Tuohy of the Cleveland Clinic and his team of researchers published their findings about the first preventive breast cancer vaccine in the prestigious journal Nature Medicine. The Pink Vaccine was found to be 100 percent effective in preventing breast cancer in mice that were bred to develop the disease. In the control group, all of the mice developed breast cancer while those who received the vaccination did not.

Tuohy’s team used the protein alpha-lactalbumin as the primary target for his vaccine and found that it both prevented breast cancer and stopped the growth of already existing tumors in animal models. Alpha-lactalbumin is found in the majority of women who are diagnosed with breast cancer, but not in healthy women other than those who are nursing. The plan would be to vaccinate women who are past child-bearing age.

We believe that this vaccine will someday be used to prevent breast cancer in adult women in the same way that vaccines prevent polio and measles in children. If it works in humans the way it works in mice, this will be monumental. We could eliminate breast cancer.

Dr. Vincent Tuohy

Immunologist, Cleveland Clinic’s Lerner Research Institute

The Next Steps

The next step to with this research is to start clinical trials and determine whether the Pink Vaccine is as safe and effective in women as it is in mice. The only problem that’s been standing in the way of Dr. Vincent Tuohy’s research is the lack of funding. Major breast cancer organizations have turned down his request for funds. The Susan G. Komen Foundation, for instance, has turned down Tuohy’s request three separate times! Avon as well as the Department of Defense also refuse to fund further research on Tuohy’s vaccine. However, despite these setbacks, a strong and growing grassroots effort by women around the globe has been developing to fund the preventive breast cancer vaccine. The Breast Health and Healing Foundation supports the research behind the Pink Vaccine. All of the donations that our Foundation receives will be going directly to funding the research behind the preventive breast cancer vaccine and the human mammary tumor virus.

Recent Vaccine News

The Uber Cure For Breast Cancer: A Preventive Vaccine

"We are not limited by science, we are limited by our ability to make good use of the information ... we already have."  Vincent DeVita, The Death Of Cancer   In the waning hours of daylight in the fall of 2015 Cindy Sullivan's life came to an end.  She'd battled the...

read more

Could a Different Type of Vaccine Prevent Breast Cancer?

By Vera Gruessner The latest news about breast cancer shows that a different type of vaccine could be beneficial in preventing this disease, according to The Guardian. Along with the ability to prevent cervical cancers, Gardasil may be effective at stopping breast...

read more

The Dangers of Drinking: Alcohol May Cause Breast Cancer

By Vera Gruessner While Breast Cancer Awareness Month drew to a close, this does not make much of an impact on the thousands of women around the country that are living with breast cancer and continually endure chemotherapy, mastectomies, lumpectomies, and the many...

read more

Cancer Doesn't Discriminate

Written by Vera Gruessner Cancer is an unbelievably devastating disease. It affects families, children, young adults, mothers, fathers, grandmothers, grandfathers, and more. Cancer doesn't discriminate. If you spend your life volunteering, being good to others, and...

read more

Imagine A World Without Mammograms, A World Without Mutilation, A World Without Financial Ruin.

Once upon a time, there was a time when leg braces and iron lungs were what rescued victims that were struck down by polio.  There was a time when young children collected dimes and put them into slots on cards, and then mailed them to the March Of Dimes to fund the...

read more

36 Newark Ave., Suite 130
Belleville, NJ  07109

(973) 450-2710

Scientific Breakthroughs Start Here!

We believe there's a better way-- and we are going to find it! Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!